Checkmate or Stalemate: Valeant’s fall from investing grace
In this session, I look at Valeant’s rise from obscure Canadian drug company to a value investing darling, and its precipitous fall in the last three weeks.
Slides: http://www.stern.nyu.edu/~adamodar/pd…
Valuation: http://www.stern.nyu.edu/~adamodar/pc…
Blog Post: http://aswathdamodaran.blogspot.com/2…
Investing in stocks can be a great way to improve your overall wealth – but...
Financial services behemoth Morgan Stanley (NYSE:MS) reported strong second quarter earnings with profits rising 47%, pushing Morgan Stanley stock higher. The firm generated $15 billion in revenue, an 11% year-over-year...
Cryptocurrency
Gambling
Investing
Net Worth
Personal Finance
Stocks
